Download PDF

Other users also viewed these articles

Case report: C3 glomerulopathy advancing atypical hemolytic uremic syndrome Muge Catikkas, Erol Demir, Yasemin Ozluk, Yasar Caliskan, Rabia Muberra Badur, Aydin Turkmen
10.1016/j.nefroe.2018.04.001
Eculizumab as a treatment for atypical hemolytic uremic syndrome secondary to carfilzomib Candela Moliz, Eduardo Gutiérrez, Teresa Cavero, Beatriz Redondo, Manuel Praga
10.1016/j.nefroe.2018.02.017
Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome Aysegul Oruc, Yavuz Ayar, Berna Aytac Vuruskan, Abdulmecit Yildiz, Nimet Aktas, Mahmut Yavuz, Mustafa Gullulu, Kamil Dilek, Alparslan Ersoy
10.1016/j.nefroe.2018.04.004